Product Information
QC HEAD CONGEST-MUCUS PE CPLT is a generic product labeled by Chain Drug Marketing Association, priced at $0.1111 per EA under NDC 83324011224. Its NADAC has been published 96 times since Dec 4, 2024.
QC HEAD CONGEST-MUCUS PE CPLT
ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDEStrength
325; 200; 5 mg/1; mg/1; mg/1
Manufacturer
Chain Drug Marketing AssociationNDC
83324011224
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
8/6/2024
Pharmacological Classes
Price Statistics
The NADAC for QC HEAD CONGEST-MUCUS PE CPLT has been published 96 times since Dec 4, 2024, and over the history we have for it it has declined 3.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1111 per EA |
|---|---|
| All-time high | $0.1176 (Jul 16, 2025) |
| All-time low | $0.1047 (Aug 19, 2026) |
| 52-week high | $0.1167 |
| 52-week low | $0.1047 |
| Median price | $0.1140 |
| Average price | $0.1132 |
| Largest weekly change | +6.1% (Sep 23, 2026) |
| Weeks tracked | 96 |
| Tracking since | Dec 4, 2024 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chain Drug Marketing Association manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QC HEAD CONGEST-MUCUS PE CPLT?
The current National Average Drug Acquisition Cost (NADAC) for QC HEAD CONGEST-MUCUS PE CPLT, manufactured by Chain Drug Marketing Association, is $0.1111 per EA (NDC 83324011224), effective Sep 30, 2026.
How has the price of QC HEAD CONGEST-MUCUS PE CPLT changed over time?
Over the history we have for it, the NADAC for QC HEAD CONGEST-MUCUS PE CPLT has declined 3.0%. It has been tracked across 96 weekly CMS publications since Dec 4, 2024.
What are the highest and lowest recorded NADAC prices for QC HEAD CONGEST-MUCUS PE CPLT?
Since Dec 4, 2024, the NADAC for QC HEAD CONGEST-MUCUS PE CPLT has ranged from a low of $0.1047 (Aug 19, 2026) to a high of $0.1176 (Jul 16, 2025), with a median of $0.1140 per EA.
Are there cheaper alternatives to QC HEAD CONGEST-MUCUS PE CPLT?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as QC HEAD CONGEST-MUCUS PE CPLT in a comparable dosage form, but none are currently priced below it.
Who manufactures QC HEAD CONGEST-MUCUS PE CPLT?
QC HEAD CONGEST-MUCUS PE CPLT (NDC 83324011224) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.